Citadel Advisors
SMTI icon

Citadel Advisors’s Sanara MedTech SMTI Stock Holding History

Citadel Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$535K Buy
31,113
+20,965
+207% +$431K ﹤0.01% 9138
2025
Q4 		$237K Sell
10,148
-8,906
-47% -$230K ﹤0.01% 10677
2025
Q3 		$605K Sell
19,054
-3,719
-16% -$112K ﹤0.01% 8665
2025
Q2 		$647K Buy
22,773
+7,350
+48% +$220K ﹤0.01% 8021
2025
Q1 		$476K Sell
15,423
-6,561
-30% -$223K ﹤0.01% 8582
2024
Q4 		$730K Buy
21,984
+1,491
+7% +$50.6K ﹤0.01% 7716
2024
Q3 		$620K Buy
+20,493
New +$639K ﹤0.01% 7808
2024
Q2 		– Sell
-8,038
Closed -$297K – 15307
2024
Q1 		$297K Sell
8,038
-2,574
-24% -$96.2K ﹤0.01% 9467
2023
Q4 		$436K Buy
10,612
+943
+10% +$30.3K ﹤0.01% 8401
2023
Q3 		$301K Sell
9,669
-8,244
-46% -$319K ﹤0.01% 9164
2023
Q2 		$718K Sell
17,913
-235
-1% -$9.61K ﹤0.01% 7136
2023
Q1 		$749K Buy
18,148
+5,578
+44% +$235K ﹤0.01% 7414
2022
Q4 		$572K Sell
12,570
-2,262
-15% -$77.9K ﹤0.01% 7967
2022
Q3 		$440K Buy
14,832
+3,878
+35% +$109K ﹤0.01% 8744
2022
Q2 		$229K Buy
+10,954
New +$256K ﹤0.01% 10415
2021
Q4 		– Sell
-5,997
Closed -$204K – 14687
2021
Q3 		$204K Buy
+5,997
New +$215K ﹤0.01% 11951

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors's SMTI Position: Q1 2026 in Review

Citadel Advisors increased its Sanara MedTech (SMTI) stake by 207% in Q1 2026, buying an estimated $431K and bringing the position to 31,113 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #9138.

Citadel Advisors first reported a position in SMTI in Q3 2021 and has held it in 16 quarters since. The position peaked at $749K in Q1 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Citadel Advisors held 31,113 shares of Sanara MedTech worth $535K as of Q1 2026.
  • Citadel Advisors bought 20,965 Sanara MedTech shares in Q1 2026, an estimated $431K.
  • Sanara MedTech made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9138 holding.
  • Citadel Advisors first reported a position in Sanara MedTech in Q3 2021 and has held it in 16 quarters since.
  • Citadel Advisors's Sanara MedTech position peaked at $749K in Q1 2023.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.